Literature DB >> 3346191

Tirandalydigin, a novel tetramic acid of the tirandamycin-streptolydigin type. II. Isolation and structural characterization.

G M Brill1, J B McAlpine, D Whittern.   

Abstract

Tirandalydigin a structurally unique hybrid of the tirandamycin-streptolydigin families of tetramic acid antibiotics has been isolated from the fermentation beers of Streptomyces sp. AB-1006A-9. The structure of this anti-anaerobic antibiotic has been characterized based upon NMR, UV and mass spectrometric data.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3346191     DOI： 10.7164/antibiotics.41.36

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


  5 in total

1.  Synthesis of Chiral Tetramic Acids: Preparation of (S)-5-Benzylpyrrolidine-2,4-dione from L-Phenylalanine Methyl Ester Hydrochloride.

Authors:  Kyle M Lambert; Austin W Medley; Amy C Jackson; Lauren E Markham; John L Wood
Journal:  Organic Synth       Date:  2019

2.  Chemical synthesis enables biochemical and antibacterial evaluation of streptolydigin antibiotics.

Authors:  Sergey V Pronin; Anthony Martinez; Konstantin Kuznedelov; Konstantin Severinov; Howard A Shuman; Sergey A Kozmin
Journal:  J Am Chem Soc       Date:  2011-07-20       Impact factor: 15.419

3.  Isolation and characterization of tirandamycins from a marine-derived Streptomyces sp.

Authors:  Jacob C Carlson; Shengying Li; Douglas A Burr; David H Sherman
Journal:  J Nat Prod       Date:  2009-11       Impact factor: 4.050

4.  Thiol Probes To Detect Electrophilic Natural Products Based on Their Mechanism of Action.

Authors:  Gabriel Castro-Falcón; Dongyup Hahn; Daniela Reimer; Chambers C Hughes
Journal:  ACS Chem Biol       Date:  2016-06-28       Impact factor: 5.100

5.  A New Analogue of Echinomycin and a New Cyclic Dipeptide from a Marine-Derived Streptomyces sp. LS298.

Authors:  Xin Zhen; Ting Gong; Fu Liu; Pei-Cheng Zhang; Wan-Qi Zhou; Yan Li; Ping Zhu
Journal:  Mar Drugs       Date:  2015-11-18       Impact factor: 5.118
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.